Overview:
In an allergy condition, the human immune system starts reacting abnormally as it gets exposed to specific foreign substances called allergens. These can be mites, dust particles, animal proteins, pollens, food, medications and molds. Allergies can be seasonal or perennial. Change in weather results into seasonal allergies, while perennial allergies occur due to allergens such as food, medication, pet hair or dander. Allergy symptoms include runny & blocked nose, itching, wheezing, watery eyes, breath shortness, eyes or face, lip swelling and others.
The Europe and Japan allergy immunotherapy market is expected to reach value of US$ 1,228.37 Mn in 2022 and show a CAGR of 8.1% over the forecast period (2022-2030).
Get a Sample Copy of this Report @
https://www.coherentmarketinsights.com/insight/request-sample/5037
Market Drivers:
Major players in the market are focusing on product approvals, which in turn is expected to propel growth of the Europe and Japan allergy immunotherapy market during the forecast period. For instance, HAL Allergy B.B. was granted registration in 2018, for SUBLIVAC Trees 40.000 AUN/ml and SUBLIVAC Birch 40.000 AUN/ml in Germany.
Moreover, key players in the market are also focusing research and development activities for developing allergy immunotherapy treatments and this is projected to boost growth of the Europe and Japan allergy immunotherapy market during the forecast period.
Impact of COVID-19:
The outbreak of coronavirus in China affected more than 100 countries all over the world. The epidemic of COVID-19 disrupted several industries. The Europe and Japan allergy immunotherapy market was adversely impacted by the pandemic as transportation operations were disrupted during this period. As per the European Medicine Agency (EMA), in March 2020, the European medicine regulatory network was established in response to the COVID-19 pandemic for development of methods to collect and share data whenever required for medicines in European Union. During the pandemic, people ha to adopt social distancing and maintaining hygiene. Several research activities were hampered during this period, which adversely impacted the market growth.
Market Restraints:
Harmful effects of allergy immunotherapy such as oral and ear pruritus, swelling of tongue, pharynx and tongue, throat irritation are likely to hamper growth of the Europe and Japan allergy immunotherapy market over the forecast period. National Center for Biology Information published article in 2019, which reported that due to harmful side effects of allergy immunotherapy, 4 to 7% of patients in the U.S. dropped out of clinical trials.
Regional Insights:
Europe among regions is anticipated to witness significant growth in the Europe and Japan allergy immunotherapy market over the forecast period. This growth can be attributed to rise in product approval by regulatory organizations. For instance, ALK- Abelló A/S announced to completed process for marketing authorization in June 2019, for tree sublingual allergy immunotherapy (SLIT) tablet across 17 nations in the Europe under the brand name of the tree SLIT-table.
Get a 20% Discount on Direct Purchase @ https://www.coherentmarketinsights.com/insight/request-discount/5037
Key Players:
Major players active in the Europe and Japan allergy immunotherapy market are DESENTUM OY, Novartis International AG, Torii Pharmaceutical Co., Ltd., Merck & Co., Inc., Allergy Therapeutics Plc., ALK-Abelló A/S, Regeneron Pharmaceuticals, Inc., Stallergenes Greer, Aimmune Therapeutics, Inc., and HAL Allergy B.V.
Reasons to buy this Europe and Japan Allergy Immunotherapy Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Europe and Japan Allergy Immunotherapy Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Europe and Japan Allergy Immunotherapy Market
◘ Leading company profiles reveal details of key Europe and Japan Allergy Immunotherapy Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Europe and Japan Allergy Immunotherapy Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Europe and Japan Allergy Immunotherapy Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Europe and Japan Allergy Immunotherapy Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @
https://www.coherentmarketinsights.com/insight/buy-now/5037
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Europe and Japan Allergy Immunotherapy Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Europe and Japan Allergy Immunotherapy Industry Impact
Chapter 2 Global Europe and Japan Allergy Immunotherapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Europe and Japan Allergy Immunotherapy (Volume and Value) by Type
2.3 Global Europe and Japan Allergy Immunotherapy (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Europe and Japan Allergy Immunotherapy Sales, Consumption, Export, Import by Regions
Chapter 5 North America Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 6 East Asia Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 7 Europe Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 8 South Asia Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 9 Southeast Asia Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 10 Middle East Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 11 Africa Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 12 Oceania Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 13 South America Europe and Japan Allergy Immunotherapy Market Analysis
Chapter 14 Company Profiles and Key Figures in Europe and Japan Allergy Immunotherapy Business
Chapter 15 Global Europe and Japan Allergy Immunotherapy Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology….
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837